Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine vs Bupivacaine/Dexamethasone for Robotic Thoracic Surgery
NCT03906617Phase 4Recruiting
- Sponsor
- Cooper University Health Care
- Start
- Apr 2019
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of liposomal bupivacaine in postoperative pain (2 arms), sponsored by Cooper University Health Care. Primary endpoint: Visual Analogue Scale pain scores at 24 hours. Started Apr 2019; status: recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03906617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03906617.